Are you Dr. Pollock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3811 Ohara St
Pittsburgh, PA 15213Phone+1 412-624-1000
Summary
- Dr. Bruce Pollock, MD is a psychiatrist in Pittsburgh, Pennsylvania.
Education & Training
University of Toronto Faculty of MedicineClass of 1979
Clinical Trials
- Serotonergic Pharmacotherapy for Agitation of Dementia Start of enrollment: 1995 Sep 01
- Treating Behavioral Disturbances in Individuals With Dementia Start of enrollment: 2000 Jan 01
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 109 citationsExtent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease.Sanjeev Kumar, Reza Zomorrodi, Zaid Ghazala, Michelle S. Goodman, Daniel M. Blumberger
JAMA Psychiatry. 2017-12-01 - 195 citationsMeta-analysis of serotonin transporter polymorphisms and affective disorders.Francis E. Lotrich, Bruce G. Pollock
Psychiatric Genetics. 2004-09-01 - 12 citationsMild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adults.Breno S. Diniz, Érica Leandro Marciano Vieira, Ana Paula Mendes-Silva, Christopher R. Bowie, Meryl A. Butters
Alzheimer's & Dementia. 2021-01-01
Press Mentions
Annual Meeting 2021 Preliminary Program GuideMarch 1st, 2021
Dementia Study SHOCK - Experts Warn Link to Alcohol Could Be WORSE Than ThoughtFebruary 27th, 2018
Alcohol Consumption Biggest Risk Factor for Dementia: StudyFebruary 23rd, 2018- Join now to see all
Grant Support
- Maintenance Therapies In Late-Life Depression-IiiNational Institute Of Mental Health2005–2008
- Geropsychopharmacology: Enhancing Benefit, Reducing RiskNational Institute Of Mental Health2002–2006
- Continuation Pharmacotherapy For Agitation Of DementiaNational Center For Research Resources2004–2005
- Atypical Antipsychotics: Determinants Of ConcentrationNational Institute Of Mental Health2001–2004
- Continuation Pharmacotherapy For Agitation Of DementiaNational Institute Of Mental Health2000–2004
- Core--Geriatric PsychopharmacologyNational Institute Of Mental Health2000–2002
- Serotonergic Pharmacotherapy For Agitation Of DementiaNational Center For Research Resources2000–2002
- Geropsychopharmacology--Enhancing Benefit, Reducing RiskNational Institute Of Mental Health1997–2001
- Core--Geriatric Clinical PsychopharmacologyNational Institute Of Mental Health1996–1999
- Serotonergic Pharmacotherapy For Agitation Of DementiaNational Institute Of Mental Health1995–1999
- Geriatric Neuroleptic Metabolism And ToxicityNational Institute Of Mental Health1992–1996
